首页 > 最新文献

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih最新文献

英文 中文
Efficacy of Raw Corn Starch in Insulinoma-Related Hypoglycemia: A Promising Supportive Therapy. 生玉米淀粉对胰岛素瘤导致的低血糖症的疗效:一种前景看好的辅助疗法
Rong-Rong Li, Wei Chen, Xin-Hua Xiao, Miao Yu, Fan Ping, Lian Duan
Objective To investigate the efficacy of raw corn starch (RCS) in clinical management of insulinoma-induced hypoglycemia.Methods We retrospectively collected clinical data of insulinoma patients who received RCS-supplemented diet preoperatively, and analyzed the therapeutic effects of the RCS intervention on blood glucose control, weight change, and its adverse events.Results The study population consisted of 24 case of insulinoma patients, 7 males and 17 females, aged 46.08 ± 14.15 years. Before RCS-supplemented diet, all patients had frequent hypoglycemic episodes (2.51 ± 3.88 times/week), concurrent with neuroglycopenia (in 83.3% of patients) and autonomic manifestations (in 75.0% of patients), with the median fasting blood glucose (FBG) of 2.70 [interquartile range (IQR): 2.50-2.90] mmol/L. The patients' weight increased by 0.38 (IQR: 0.05-0.65) kg per month, with 8 (33.3%) cases developing overweight and 7 (29.2%) cases developing obesity. All patients maintained the RCS-supplemented diet until they underwent tumor resection (23 cases) and transarterial chemoembolization for liver metastases (1 case). For 19 patients receiving RCS throughout the day, the median FBG within one week of nutritional management was 4.30 (IQR: 3.30-5.70) mmol/L, which was a significant increase compared to pre-nutritional level [2.25 (IQR: 1.60-2.90) mmol/L; P = 0.000]. Of them, 10 patients receiving RCS throughout the day for over four weeks had sustained improvement in FBG compared to pre-treatment [3.20 (IQR: 2.60-3.95) mmol/L vs. 2.15 (IQR: 1.83-2.33) mmol/L; P = 0.000). Five patients who received RCS only at night also had a significant increase in FBG within one week of nutritional management [3.50 (IQR: 2.50-3.65) mmol/L vs. 2.20 (IQR:1.80-2.60) mmol/L; P = 0.000], but only one patient who continued to receive RCS for over 4 weeks did not have a significant improvement in FBG. No improvement in weight gain was observed upon RCS supplementation. Mild diarrhea (2 cases) and flatulence (1 case) occurred, and were relieved by reduction of RCS dose.Conclusion The RCS-supplemented diet is effective in controlling insulinoma-induced hypoglycemia.
目的 探讨生玉米淀粉(RCS)在胰岛素瘤所致低血糖临床治疗中的疗效。方法 回顾性收集术前接受RCS辅助饮食的胰岛素瘤患者的临床资料,分析RCS干预对血糖控制、体重变化及其不良反应的治疗效果。补充 RCS 饮食前,所有患者均频繁发生低血糖(2.51 ± 3.88 次/周),同时伴有神经性糖耐量减低症(83.3% 的患者)和自主神经表现(75.0% 的患者),空腹血糖(FBG)中位数为 2.70 [四分位数间距(IQR):2.50-2.90] mmol/L。患者体重每月增加 0.38(IQR:0.05-0.65)千克,其中 8 例(33.3%)发展为超重,7 例(29.2%)发展为肥胖。所有患者在接受肿瘤切除术(23 例)和经动脉化疗栓塞治疗肝转移瘤(1 例)之前,一直保持补充 RCS 的饮食习惯。19 名全天接受 RCS 的患者在营养管理一周内的 FBG 中位数为 4.30(IQR:3.30-5.70)mmol/L,与营养前水平 [2.25 (IQR:1.60-2.90)mmol/L;P = 0.000]相比显著增加。其中,10 名患者全天接受 RCS 超过四周,与治疗前相比,FBG 有持续改善 [3.20 (IQR: 2.60-3.95) mmol/L vs. 2.15 (IQR: 1.83-2.33) mmol/L;P = 0.000]。五名仅在夜间接受 RCS 的患者的 FBG 也在营养管理一周内显著增加 [3.50 (IQR: 2.50-3.65) mmol/L vs. 2.20 (IQR:1.80-2.60) mmol/L;P = 0.000],但只有一名持续接受 RCS 超过 4 周的患者的 FBG 没有显著改善。补充 RCS 后体重增加没有改善。出现轻度腹泻(2 例)和胀气(1 例),减少 RCS 剂量后症状缓解。
{"title":"Efficacy of Raw Corn Starch in Insulinoma-Related Hypoglycemia: A Promising Supportive Therapy.","authors":"Rong-Rong Li, Wei Chen, Xin-Hua Xiao, Miao Yu, Fan Ping, Lian Duan","doi":"10.24920/004329","DOIUrl":"https://doi.org/10.24920/004329","url":null,"abstract":"Objective To investigate the efficacy of raw corn starch (RCS) in clinical management of insulinoma-induced hypoglycemia.Methods We retrospectively collected clinical data of insulinoma patients who received RCS-supplemented diet preoperatively, and analyzed the therapeutic effects of the RCS intervention on blood glucose control, weight change, and its adverse events.Results The study population consisted of 24 case of insulinoma patients, 7 males and 17 females, aged 46.08 ± 14.15 years. Before RCS-supplemented diet, all patients had frequent hypoglycemic episodes (2.51 ± 3.88 times/week), concurrent with neuroglycopenia (in 83.3% of patients) and autonomic manifestations (in 75.0% of patients), with the median fasting blood glucose (FBG) of 2.70 [interquartile range (IQR): 2.50-2.90] mmol/L. The patients' weight increased by 0.38 (IQR: 0.05-0.65) kg per month, with 8 (33.3%) cases developing overweight and 7 (29.2%) cases developing obesity. All patients maintained the RCS-supplemented diet until they underwent tumor resection (23 cases) and transarterial chemoembolization for liver metastases (1 case). For 19 patients receiving RCS throughout the day, the median FBG within one week of nutritional management was 4.30 (IQR: 3.30-5.70) mmol/L, which was a significant increase compared to pre-nutritional level [2.25 (IQR: 1.60-2.90) mmol/L; P = 0.000]. Of them, 10 patients receiving RCS throughout the day for over four weeks had sustained improvement in FBG compared to pre-treatment [3.20 (IQR: 2.60-3.95) mmol/L vs. 2.15 (IQR: 1.83-2.33) mmol/L; P = 0.000). Five patients who received RCS only at night also had a significant increase in FBG within one week of nutritional management [3.50 (IQR: 2.50-3.65) mmol/L vs. 2.20 (IQR:1.80-2.60) mmol/L; P = 0.000], but only one patient who continued to receive RCS for over 4 weeks did not have a significant improvement in FBG. No improvement in weight gain was observed upon RCS supplementation. Mild diarrhea (2 cases) and flatulence (1 case) occurred, and were relieved by reduction of RCS dose.Conclusion The RCS-supplemented diet is effective in controlling insulinoma-induced hypoglycemia.","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"75 19","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140964623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Strategies of Surface Modifications to Polyurethane Biomaterials for Vascular Grafts. 用于血管移植物的聚氨酯生物材料表面改性的当前策略。
Huai-Gu Huang, Tao Xiang, Yue-Xin Chen

As the number of patients suffering from cardiovascular diseases and peripheral vascular diseases rises, the constraints of autologous transplantation remain unavoidable. As a result, artificial vascular grafts must be developed. Adhesion of proteins, platelets and bacteria on implants can result in stenosis, thrombus formation, and postoperative infection, which can be fatal for an implantation. Polyurethane, as a commonly used biomaterial, has been modified in various ways to deal with the adhesions of proteins, platelets, and bacteria and to stimulate endothelium adhesion. In this review, we briefly summarize the mechanisms behind adhesions, overview the current strategies of surface modifications of polyurethane biomaterials used in vascular grafts, and highlight the challenges that need to be addressed in future studies, aiming to gain a more profound understanding of how to develop artificial polyurethane vascular grafts with an enhanced implantation success rate and reduced side effect.

随着心血管疾病和外周血管疾病患者人数的增加,自体移植的局限性仍然不可避免。因此,必须开发人工血管移植物。蛋白质、血小板和细菌在植入物上的附着会导致血管狭窄、血栓形成和术后感染,这对植入物来说可能是致命的。聚氨酯作为一种常用的生物材料,在处理蛋白质、血小板和细菌粘附以及刺激内皮粘附方面有多种改良方法。在这篇综述中,我们简要总结了粘附背后的机制,概述了目前用于血管移植物的聚氨酯生物材料的表面改性策略,并强调了未来研究中需要应对的挑战,目的是更深入地了解如何开发能提高植入成功率并减少副作用的人工聚氨酯血管移植物。
{"title":"Current Strategies of Surface Modifications to Polyurethane Biomaterials for Vascular Grafts.","authors":"Huai-Gu Huang, Tao Xiang, Yue-Xin Chen","doi":"10.24920/004178","DOIUrl":"10.24920/004178","url":null,"abstract":"<p><p>As the number of patients suffering from cardiovascular diseases and peripheral vascular diseases rises, the constraints of autologous transplantation remain unavoidable. As a result, artificial vascular grafts must be developed. Adhesion of proteins, platelets and bacteria on implants can result in stenosis, thrombus formation, and postoperative infection, which can be fatal for an implantation. Polyurethane, as a commonly used biomaterial, has been modified in various ways to deal with the adhesions of proteins, platelets, and bacteria and to stimulate endothelium adhesion. In this review, we briefly summarize the mechanisms behind adhesions, overview the current strategies of surface modifications of polyurethane biomaterials used in vascular grafts, and highlight the challenges that need to be addressed in future studies, aiming to gain a more profound understanding of how to develop artificial polyurethane vascular grafts with an enhanced implantation success rate and reduced side effect.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":" ","pages":"279-285"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9874253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative Blood Pressure Lability Acts as a Key Mediator in the Impacts of Goal-Directed Fluid Therapy on Postoperative Complications in Patients Undergoing Major Spine Surgery. 术中血压不稳定是目标导向液体疗法对脊柱大手术患者术后并发症影响的关键中介。
Lu Che, Jia-Wen Yu, Yue-Lun Zhang, Li Xu, Yu-Guang Huang

Objective Although goal-directed fluid therapy (GDFT) has been proven to be effective in reducing the incidence of postoperative complications, the underlying mechanisms remain unknown. The aim of this study was to examine the mediating role of intraoperative hemodynamic lability in the association between GDFT and the incidence of postoperative complications. We further tested the role of this mediation effect using mean arterial pressure, a hemodynamic indicator. Methods This secondary analysis used the dataset of a completed nonrandomized controlled study to investigate the effect of GDFT on the incidence of postoperative complications in patients undergoing posterior spine arthrodesis. We used a simple mediation model to test whether there was a mediation effect of average real variability between the association of GDFT and postoperative complications. We conducted mediation analysis using the mediation package in R (version 3.1.2), based on 5,000 bootstrapped samples, adjusting for covariates. Results Among the 300 patients in the study, 40% (120/300) developed postoperative complications within 30 days. GDFT was associated with fewer 30-day postoperative complications after adjustment for confounders (odds ratio: 0.460, 95% CI: 0.278, 0.761; P = 0.003). The total effect of GDFT on postoperative complications was -0.18 (95% CI: -0.28, -0.07; P < 0.01). The average causal mediation effect was -0.08 (95% CI: -0.15, -0.04; P < 0.01). The average direct effect was -0.09 (95% CI: -0.20, 0.03; P = 0.17). The proportion mediated was 49.9% (95% CI: 18.3%, 140.0%). Conclusions The intraoperative blood pressure lability mediates the relationship between GDFT and the incidence of postoperative complications. Future research is needed to clarify whether actively reducing intraoperative blood pressure lability can prevent postoperative complications.

目的 虽然目标导向液体疗法(GDFT)已被证实能有效降低术后并发症的发生率,但其潜在机制仍不清楚。本研究旨在探讨术中血流动力学不稳定性在 GDFT 与术后并发症发生率之间的中介作用。我们使用血液动力学指标平均动脉压进一步检验了这种中介效应的作用。方法 这项二次分析使用了一项已完成的非随机对照研究的数据集,以研究 GDFT 对脊柱后路关节置换术患者术后并发症发生率的影响。我们使用了一个简单的中介模型来检验平均实际变异性在 GDFT 与术后并发症之间是否存在中介效应。我们使用 R 中的中介包(3.1.2 版)进行了中介分析,基于 5000 个引导样本,并对协变量进行了调整。结果 在参与研究的 300 名患者中,40% 的患者(120/300)在 30 天内出现了术后并发症。在对混杂因素进行调整后,GDFT 与较少的 30 天术后并发症相关(几率比:0.460,95% CI:0.278,0.761;P = 0.003)。GDFT对术后并发症的总影响为-0.18(95% CI:-0.28,-0.07;P < 0.01)。平均因果中介效应为-0.08 (95% CI: -0.15, -0.04; P < 0.01)。平均直接效应为-0.09 (95% CI: -0.20, 0.03; P = 0.17)。介导比例为 49.9% (95% CI: 18.3%, 140.0%)。结论 术中血压不稳定介导了 GDFT 与术后并发症发生率之间的关系。未来的研究需要明确积极降低术中血压不稳定性是否能预防术后并发症。
{"title":"Intraoperative Blood Pressure Lability Acts as a Key Mediator in the Impacts of Goal-Directed Fluid Therapy on Postoperative Complications in Patients Undergoing Major Spine Surgery.","authors":"Lu Che, Jia-Wen Yu, Yue-Lun Zhang, Li Xu, Yu-Guang Huang","doi":"10.24920/004202","DOIUrl":"10.24920/004202","url":null,"abstract":"<p><p>Objective Although goal-directed fluid therapy (GDFT) has been proven to be effective in reducing the incidence of postoperative complications, the underlying mechanisms remain unknown. The aim of this study was to examine the mediating role of intraoperative hemodynamic lability in the association between GDFT and the incidence of postoperative complications. We further tested the role of this mediation effect using mean arterial pressure, a hemodynamic indicator. Methods This secondary analysis used the dataset of a completed nonrandomized controlled study to investigate the effect of GDFT on the incidence of postoperative complications in patients undergoing posterior spine arthrodesis. We used a simple mediation model to test whether there was a mediation effect of average real variability between the association of GDFT and postoperative complications. We conducted mediation analysis using the mediation package in R (version 3.1.2), based on 5,000 bootstrapped samples, adjusting for covariates. Results Among the 300 patients in the study, 40% (120/300) developed postoperative complications within 30 days. GDFT was associated with fewer 30-day postoperative complications after adjustment for confounders (odds ratio: 0.460, 95% <i>CI</i>: 0.278, 0.761; <i>P</i> = 0.003). The total effect of GDFT on postoperative complications was -0.18 (95% <i>CI</i>: -0.28, -0.07; <i>P</i> < 0.01). The average causal mediation effect was -0.08 (95% <i>CI</i>: -0.15, -0.04; <i>P</i> < 0.01). The average direct effect was -0.09 (95% <i>CI</i>: -0.20, 0.03; <i>P</i> = 0.17). The proportion mediated was 49.9% (95% <i>CI</i>: 18.3%, 140.0%). Conclusions The intraoperative blood pressure lability mediates the relationship between GDFT and the incidence of postoperative complications. Future research is needed to clarify whether actively reducing intraoperative blood pressure lability can prevent postoperative complications.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":" ","pages":"257-264"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10153046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Great Imitator: Atypical Cutaneous Manifestations of Primary Syphilitic Chancre. 伟大的模仿者:原发性梅毒下疳的非典型皮肤表现。
Hui-Zi Gong, Meng-Yin Wu, Jun Li, He-Yi Zheng

Objective To analyze the reasons of misdiagnosis of primary syphilitic chancre and strengthen the understanding of atypical features of this disease. Methods A case series of twenty-seven challenging primary syphilis patients who were not immediately recognized as chancre was included in our study. The clinical data including the patients' age, sex, skin lesions, HIV status, syphilis serologic test results, treatment, and follow-up results were collected. Hematoxylin-eosin and immunohistochemistry staining of skin biopsy sections were reviewed. Results Four female cases with extragenital chancres presenting as erythema or erosive skin lesions on the nipple were misdiagnosed as Paget's disease or eczema. The disorder of missed or misdiagnosed male cases manifested as syphilitic balanitis or multiple chancres on the penis root and adjacent pubis rather than coronal sulcus or frenum. Patients with nonreactive nontreponemal tests at initial presentation were also easily missed or misdiagnosed. Conclusion Primary syphilis presenting as multiple lesions rather than a single chancre, at atypical locations, or with a nonreactive nontreponemal test result, tends to be missed or misdiagnosed.

目的分析原发性梅毒下疳的误诊原因,加强对该病非典型特征的认识。方法选取27例未被立即识别为下疳的原发性梅毒患者作为研究对象。收集患者的年龄、性别、皮肤病变情况、HIV感染情况、梅毒血清学检测结果、治疗情况及随访结果等临床资料。复习了皮肤活检切片的苏木精-伊红和免疫组织化学染色。结果4例以乳头红斑或糜烂性皮损为主要表现的女性生殖器外肿物被误诊为Paget病或湿疹。男性漏诊或误诊的疾病表现为梅毒性龟头炎或阴茎根及邻近耻骨多发,冠状沟或系带未见。在初次就诊时进行无反应性非螺旋体试验的患者也很容易漏诊或误诊。结论原发性梅毒表现为多发而非单一下疳,部位不典型,非螺旋体检查无反应,易被漏诊或误诊。
{"title":"The Great Imitator: Atypical Cutaneous Manifestations of Primary Syphilitic Chancre.","authors":"Hui-Zi Gong,&nbsp;Meng-Yin Wu,&nbsp;Jun Li,&nbsp;He-Yi Zheng","doi":"10.24920/003842","DOIUrl":"https://doi.org/10.24920/003842","url":null,"abstract":"<p><p>Objective To analyze the reasons of misdiagnosis of primary syphilitic chancre and strengthen the understanding of atypical features of this disease. Methods A case series of twenty-seven challenging primary syphilis patients who were not immediately recognized as chancre was included in our study. The clinical data including the patients' age, sex, skin lesions, HIV status, syphilis serologic test results, treatment, and follow-up results were collected. Hematoxylin-eosin and immunohistochemistry staining of skin biopsy sections were reviewed. Results Four female cases with extragenital chancres presenting as erythema or erosive skin lesions on the nipple were misdiagnosed as Paget's disease or eczema. The disorder of missed or misdiagnosed male cases manifested as syphilitic balanitis or multiple chancres on the penis root and adjacent pubis rather than coronal sulcus or frenum. Patients with nonreactive nontreponemal tests at initial presentation were also easily missed or misdiagnosed. Conclusion Primary syphilis presenting as multiple lesions rather than a single chancre, at atypical locations, or with a nonreactive nontreponemal test result, tends to be missed or misdiagnosed.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"36 4","pages":"279-283"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39787058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Does Prior Cancer Have an Influence on the Survival Outcomes of Patients with Localized Pancreatic Neuroendocrine Tumors? 既往癌症是否影响局限性胰腺神经内分泌肿瘤患者的生存结局?
Liang Wang, Gang Li, Yun-Tao Bing, Mao-Lin Tian, Hang-Yan Wang, Chun-Hui Yuan, Dian-Rong Xiu

Objective To investigate the impact of prior non-pancreatic cancer on the survival outcomes of patients with localized pancreatic neuroendocrine tumors (PanNETs). Methods We reviewed the Surveillance, Epidemiology, and End Results database and selected patients with localized PanNETs diagnosed between 1973 and 2015. We divided the patients into two groups according to the presence or absence of prior non-pancreatic malignancy. Before and after propensity score matching, we compared the clinicopathological characteristics and studied the overall survival and cancer-specific survival. Results A total of 357 (12.9%) of 2778 patients with localized PanNETs had prior cancer. A total of 1211 cases with only a localized PanNET and 133 cases with a localized PanNET and prior cancer had complete data and met the inclusion criteria of the current study. Patients with prior cancer were associated with advanced age (>65 years, 57.9% prior cancer vs. 31.0% no prior cancer, P<0.001), later year of diagnosis (87.2% vs. 80.2%, P=0.049), a higher proportion of poorly differentiated/undifferentiated grade tumors (4.5% vs. 1.5%, P=0.025), and a higher proportion of no primary site surgery (19.5% vs. 10.4%, P=0.003). Prostate (29.32%), breast (18.05%), other genitourinary and retroperitoneal (16.54%), and gastrointestinal (12.78%) cancers were the most common prior cancer types. Most of the prior cancers (95.49%) were localized and regional, and only 4.51% of the prior cancers were distant. Patients with interval periods between the prior cancer and PanNET of ≤36 months, 36-60 months, 60-120 months, and >120 months accounted for 33.08%, 13.53%, 24.06%, and 29.32% of all cases with prior cancers, respectively. Univariate and multivariate Cox proportional hazards analyses were performed. The presence/absence of prior cancers did not impact survival outcomes of patients with localized PanNETs before and after propensity score matching (PSM). Further subgroups analysis showed that, patients with localized PanNETs and prior distant cancer had worse cancer-specific survival than patients with prior local/regional cancer or patients without prior cancer (P<0.001). No significant differences in cancer-specific survival were observed in terms of the different sites of the prior cancers and the different interval periods of prior cancers and PanNETs (P<0.05). Conclusions Patients with localized PanNETs and a history of prior cancer had survival outcomes that were comparable to those of patients with no history of prior cancer. Patients with localized PanNETs and prior cancer could be candidates for clinical trials if they satisfy all other conditions; aggressive and potentially curative therapies should be offered to these patients.

目的探讨既往非胰腺癌对局限性胰腺神经内分泌肿瘤(PanNETs)患者生存结局的影响。方法回顾监测、流行病学和最终结果数据库,选择1973年至2015年诊断的局限性PanNETs患者。我们根据有无既往非胰腺恶性肿瘤将患者分为两组。倾向评分匹配前后比较临床病理特征,研究总生存期和肿瘤特异性生存期。结果2778例局限性PanNETs患者中有357例(12.9%)既往有肿瘤。仅有局限性PanNET的1211例和局限性PanNET合并既往癌症的133例数据完整,符合本研究的纳入标准。既往癌症患者与高龄相关(>65岁,57.9%既往癌症vs. 31.0%无既往癌症,P= 80.2%, P=0.049),低分化/未分化级肿瘤比例较高(4.5%对1.5%,P=0.025),无原发部位手术比例较高(19.5%对10.4%,P=0.003)。前列腺癌(29.32%)、乳腺癌(18.05%)、其他泌尿生殖系统和腹膜后癌(16.54%)和胃肠道癌(12.78%)是最常见的既往癌症类型。既往肿瘤大部分(95.49%)为局部和区域性,远端肿瘤仅占4.51%。既往肿瘤与PanNET间隔≤36个月、36-60个月、60-120个月和>120个月的患者分别占所有既往肿瘤患者的33.08%、13.53%、24.06%和29.32%。进行单因素和多因素Cox比例风险分析。在倾向评分匹配(PSM)前后,是否存在既往癌症并不影响局部PanNETs患者的生存结果。进一步的亚组分析显示,局部PanNETs患者和既往远处癌症患者的癌症特异性生存率低于既往局部/区域癌症患者或无既往癌症患者(PP
{"title":"Does Prior Cancer Have an Influence on the Survival Outcomes of Patients with Localized Pancreatic Neuroendocrine Tumors?","authors":"Liang Wang,&nbsp;Gang Li,&nbsp;Yun-Tao Bing,&nbsp;Mao-Lin Tian,&nbsp;Hang-Yan Wang,&nbsp;Chun-Hui Yuan,&nbsp;Dian-Rong Xiu","doi":"10.24920/003803","DOIUrl":"https://doi.org/10.24920/003803","url":null,"abstract":"<p><p>Objective To investigate the impact of prior non-pancreatic cancer on the survival outcomes of patients with localized pancreatic neuroendocrine tumors (PanNETs). Methods We reviewed the Surveillance, Epidemiology, and End Results database and selected patients with localized PanNETs diagnosed between 1973 and 2015. We divided the patients into two groups according to the presence or absence of prior non-pancreatic malignancy. Before and after propensity score matching, we compared the clinicopathological characteristics and studied the overall survival and cancer-specific survival. Results A total of 357 (12.9%) of 2778 patients with localized PanNETs had prior cancer. A total of 1211 cases with only a localized PanNET and 133 cases with a localized PanNET and prior cancer had complete data and met the inclusion criteria of the current study. Patients with prior cancer were associated with advanced age (>65 years, 57.9% prior cancer <i>vs</i>. 31.0% no prior cancer, <i>P</i><0.001), later year of diagnosis (87.2% <i>vs</i>. 80.2%, <i>P</i>=0.049), a higher proportion of poorly differentiated/undifferentiated grade tumors (4.5% <i>vs</i>. 1.5%, <i>P</i>=0.025), and a higher proportion of no primary site surgery (19.5% <i>vs</i>. 10.4%, <i>P</i>=0.003). Prostate (29.32%), breast (18.05%), other genitourinary and retroperitoneal (16.54%), and gastrointestinal (12.78%) cancers were the most common prior cancer types. Most of the prior cancers (95.49%) were localized and regional, and only 4.51% of the prior cancers were distant. Patients with interval periods between the prior cancer and PanNET of ≤36 months, 36-60 months, 60-120 months, and >120 months accounted for 33.08%, 13.53%, 24.06%, and 29.32% of all cases with prior cancers, respectively. Univariate and multivariate <i>Cox</i> proportional hazards analyses were performed. The presence/absence of prior cancers did not impact survival outcomes of patients with localized PanNETs before and after propensity score matching (PSM). Further subgroups analysis showed that, patients with localized PanNETs and prior distant cancer had worse cancer-specific survival than patients with prior local/regional cancer or patients without prior cancer (<i>P</i><0.001). No significant differences in cancer-specific survival were observed in terms of the different sites of the prior cancers and the different interval periods of prior cancers and PanNETs (<i>P</i><0.05). Conclusions Patients with localized PanNETs and a history of prior cancer had survival outcomes that were comparable to those of patients with no history of prior cancer. Patients with localized PanNETs and prior cancer could be candidates for clinical trials if they satisfy all other conditions; aggressive and potentially curative therapies should be offered to these patients.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"36 4","pages":"284-294"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39787059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Focused Cardiac Ultrasound in Combination with Lung Ultrasound on Critically Ill Patients: A Multicenter Observational Study in China. 聚焦心脏超声联合肺超声对危重病人的疗效:中国一项多中心观察研究。
Hong-Min Zhang, Lina Zhang, Li-Xia Liu, Ying Zhu, Wan-Hong Yin, Wei He, Xiu-Ling Shang, Yan-Gong Chao, Li-Wen Lv, Xiao-Ting Wang, Da-Wei Liu

Objective Focused cardiac ultrasound (FCU) and lung ultrasound (LU) are increasingly being used in critically ill patients. This study aimed to investigate the effect of FCU in combination with LU on these patients and to determine if the timing of ultrasound examination was associated with treatment change. Methods This is a multicenter cross-sectional observational study. Consecutive patients admitted to the intensive care unit (ICU) were screened for enrollment. FCU and LU were performed within the first 24 h, and treatment change was proposed by the performer based on the ultrasound results and other clinical conditions. Results Among the 992 patients included, 502 were examined within 6 h of ICU admission (early phase group), and 490 were examined after 6 h of admission (later phase group). The early phase group and the later phase group had similar proportions of treatment change (48.8% vs. 49.0%, χ 2=0.003, P=0.956). In the multivariable analysis, admission for respiratory failure was an independent variable associated with treatment change, with an odds ratio (OR) of 2.357 [95% confidence interval (CI): 1.284-4.326, P=0.006]; the timing of examination was not associated with treatment change (OR=0.725, 95%CI: 0.407-1.291, P=0.275). Conclusions FCU in combination with LU, whether performed during the early phase or later phase, had a significant impact on the treatment of critically ill patients. Patients with respiratory failure were more likely to experience treatment change after the ultrasound examination.

目的聚焦心脏超声(FCU)和肺超声(LU)在危重患者中的应用越来越广泛。本研究旨在探讨FCU联合LU对这些患者的影响,并确定超声检查的时间是否与治疗改变有关。方法采用多中心横断面观察性研究。连续入住重症监护病房(ICU)的患者被筛选入组。FCU和LU在前24 h内进行,由术者根据超声结果及其他临床情况提出治疗方案的改变。结果纳入的992例患者中,入院6 h内检查502例(早期组),入院6 h后检查490例(晚期组)。早期组与晚期组治疗改变比例相近(48.8% vs 49.0%, χ 2=0.003, P=0.956)。在多变量分析中,因呼吸衰竭入院是与治疗改变相关的独立变量,比值比(OR)为2.357[95%可信区间(CI): 1.284-4.326, P=0.006];检查时间与治疗改变无关(OR=0.725, 95%CI: 0.407-1.291, P=0.275)。结论FCU联合LU无论是在早期还是后期实施,对危重患者的治疗均有显著影响。呼吸衰竭患者在超声检查后更容易改变治疗方法。
{"title":"Effect of Focused Cardiac Ultrasound in Combination with Lung Ultrasound on Critically Ill Patients: A Multicenter Observational Study in China.","authors":"Hong-Min Zhang,&nbsp;Lina Zhang,&nbsp;Li-Xia Liu,&nbsp;Ying Zhu,&nbsp;Wan-Hong Yin,&nbsp;Wei He,&nbsp;Xiu-Ling Shang,&nbsp;Yan-Gong Chao,&nbsp;Li-Wen Lv,&nbsp;Xiao-Ting Wang,&nbsp;Da-Wei Liu","doi":"10.24920/003874","DOIUrl":"https://doi.org/10.24920/003874","url":null,"abstract":"<p><p>Objective Focused cardiac ultrasound (FCU) and lung ultrasound (LU) are increasingly being used in critically ill patients. This study aimed to investigate the effect of FCU in combination with LU on these patients and to determine if the timing of ultrasound examination was associated with treatment change. Methods This is a multicenter cross-sectional observational study. Consecutive patients admitted to the intensive care unit (ICU) were screened for enrollment. FCU and LU were performed within the first 24 h, and treatment change was proposed by the performer based on the ultrasound results and other clinical conditions. Results Among the 992 patients included, 502 were examined within 6 h of ICU admission (early phase group), and 490 were examined after 6 h of admission (later phase group). The early phase group and the later phase group had similar proportions of treatment change (48.8% <i>vs</i>. 49.0%, <i>χ</i> <sup>2</sup>=0.003, <i>P</i>=0.956). In the multivariable analysis, admission for respiratory failure was an independent variable associated with treatment change, with an odds ratio (<i>OR</i>) of 2.357 [95% confidence interval (<i>CI</i>): 1.284-4.326, <i>P</i>=0.006]; the timing of examination was not associated with treatment change (<i>OR</i>=0.725, 95%<i>CI</i>: 0.407-1.291, <i>P</i>=0.275). Conclusions FCU in combination with LU, whether performed during the early phase or later phase, had a significant impact on the treatment of critically ill patients. Patients with respiratory failure were more likely to experience treatment change after the ultrasound examination.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"36 4","pages":"257-264"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39787056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BAG3-Related Myofibrillar Myopathy Presenting as Hypercapnia: A Case Report and Literature Review. 以高碳酸血症为表现的与bag3相关的肌原纤维肌病:1例报告及文献复习。
Yan Xu, Shi-Xuan Liu, Wen-Bing Xu, Jin-Mei Luo, Jing-Wen Niu, Zhi Liu, Jin-Ming Gao, Jing-Lan Wang, Yi Dai, Meng-Zhao Wang

Objective BAG3-related myopathy is a rare condition so far reported in twenty patients worldwide. The purpose of this study was to draw attention to this rare disease and to the fact that BAG3-related myopathy should be considered as a rare differential diagnosis of hypercapnia. Methods We report a sporadic case of a 14-year-old Chinese girl with a de novo p.Pro209Leu mutation in BAG3 and reviewed the literatures for reported cases related to this mutation. Results We described a 14-year-old Chinese girl who presented with gradually appearing symptoms of hypercapnia that required assisted ventilation. The muscle biopsy and the blood whole-exome sequencing results confirmed the diagnosis of myofibrillar myopathy with a de novo p.Pro209Leu mutation in BAG3. Totally twenty-one patients from twenty families with a confirmed diagnosis of BAG3-related myopathy were reported to date, including this patient and literature review. The male to female ratio was 11:10 and most showed initial symptoms in the first decade of life. Most patients presented toe/clumsy walking or running as the onset symptom, followed by muscle weakness or atrophy. Creatine kinase levels were elevated in fourteen patients and were normal in three. Eighteen patients developed respiratory insufficiency during the disease course and thirteen (one could not tolerate non-invasive assisted ventilation) required non-invasive assisted ventilation for treatment. Except for one not reported, heart involvement was found in seventeen patients during the disease course and seven underwent heart transplantation. Z-disk streaming and aggregation could be observed in most of the patients' muscle histology. In the long-term follow-up, five patients died of cardiac or respiratory failure. Conclusion BAG3-associated myopathy is a rare type of myofibrillar myopathy. It should be considered as a rare differential diagnosis of hypercapnia.

目的bag3相关性肌病是一种罕见的疾病,目前在世界范围内报道了20例。本研究的目的是引起人们对这种罕见疾病的关注,以及bag3相关肌病应被视为高碳酸血症的罕见鉴别诊断。方法我们报告了一例14岁中国女孩的散在病例,并回顾了与该突变相关的文献。结果我们描述了一名14岁的中国女孩,她表现出逐渐出现的高碳酸血症症状,需要辅助通气。肌肉活检和血液全外显子组测序结果证实了肌纤维性肌病的诊断,并伴有BAG3中p.p pro209leu的新生突变。截至目前,共报道了来自20个家庭的21例确诊为bag3相关肌病的患者,包括该患者和文献综述。男女比例为11:10,大多数在生命的前十年出现初步症状。大多数患者以脚趾/走路或跑步笨拙为首发症状,其次是肌肉无力或萎缩。14例患者肌酸激酶水平升高,3例正常。18例患者在病程中出现呼吸功能不全,13例(1例不能耐受无创辅助通气)需要无创辅助通气治疗。除1例未报道外,17例患者在病程中发现心脏受累,其中7例接受了心脏移植。大多数患者的肌肉组织学均可见z -盘流动和聚集。在长期随访中,5名患者死于心脏或呼吸衰竭。结论bag3相关性肌病是一种少见的肌原纤维性肌病。应将其视为高碳酸血症的罕见鉴别诊断。
{"title":"<i>BAG3</i>-Related Myofibrillar Myopathy Presenting as Hypercapnia: A Case Report and Literature Review.","authors":"Yan Xu,&nbsp;Shi-Xuan Liu,&nbsp;Wen-Bing Xu,&nbsp;Jin-Mei Luo,&nbsp;Jing-Wen Niu,&nbsp;Zhi Liu,&nbsp;Jin-Ming Gao,&nbsp;Jing-Lan Wang,&nbsp;Yi Dai,&nbsp;Meng-Zhao Wang","doi":"10.24920/003883","DOIUrl":"https://doi.org/10.24920/003883","url":null,"abstract":"<p><p>Objective <i>BAG3</i>-related myopathy is a rare condition so far reported in twenty patients worldwide. The purpose of this study was to draw attention to this rare disease and to the fact that <i>BAG3</i>-related myopathy should be considered as a rare differential diagnosis of hypercapnia. Methods We report a sporadic case of a 14-year-old Chinese girl with a <i>de novo</i> p.Pro209Leu mutation in <i>BAG3</i> and reviewed the literatures for reported cases related to this mutation. Results We described a 14-year-old Chinese girl who presented with gradually appearing symptoms of hypercapnia that required assisted ventilation. The muscle biopsy and the blood whole-exome sequencing results confirmed the diagnosis of myofibrillar myopathy with a <i>de novo</i> p.Pro209Leu mutation in <i>BAG3</i>. Totally twenty-one patients from twenty families with a confirmed diagnosis of <i>BAG3</i>-related myopathy were reported to date, including this patient and literature review. The male to female ratio was 11:10 and most showed initial symptoms in the first decade of life. Most patients presented toe/clumsy walking or running as the onset symptom, followed by muscle weakness or atrophy. Creatine kinase levels were elevated in fourteen patients and were normal in three. Eighteen patients developed respiratory insufficiency during the disease course and thirteen (one could not tolerate non-invasive assisted ventilation) required non-invasive assisted ventilation for treatment. Except for one not reported, heart involvement was found in seventeen patients during the disease course and seven underwent heart transplantation. Z-disk streaming and aggregation could be observed in most of the patients' muscle histology. In the long-term follow-up, five patients died of cardiac or respiratory failure. Conclusion <i>BAG3</i>-associated myopathy is a rare type of myofibrillar myopathy. It should be considered as a rare differential diagnosis of hypercapnia.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"36 4","pages":"265-278"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39787057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substitution for In Vitro and In Vivo Tests: Computational Models from Cell Attachment to Tissue Regeneration. 替代体外和体内试验:从细胞附着到组织再生的计算模型。
Hao Huang, Chao-Zong Liu, Teng Yi, Maryam Tamaddon, Shan-Shan Yuan, Zhen-Yun Shi, Zi-Yu Liu

To get an optimal product of orthopaedic implant or regenerative medicine needs to follow trial-and-error analyses to investigate suitable product's material, structure, mechanical properites etc. The whole process from in vivo tests to clinical trials is expensive and time-consuming. Computational model is seen as a useful analysis tool to make the product development. A series of models for simulating tissue engineering process from cell attachment to tissue regeneration are reviewed. The challenging is that models for simulating tissue engineering processes are developed separately. From cell to tissue regeneration, it would go through blood injection after moving out the defect; to cell disperse and attach on the scaffold; to proliferation, migration and differentiation; and to the final part-becoming mature tissues. This paper reviewed models that related to tissue engineering process, aiming to provide an opportunity for researchers to develop a mature model for whole tissue engineering process. This article focuses on the model analysis methods of cell adhesion, nutrient transport and cell proliferation, differentiation and migration in tissue engineering. In cell adhesion model, one of the most accurate method is to use discrete phase model to govern cell movement and use Stanton-Rutland model for simulating cell attachment. As for nutrient transport model, numerical model coupling with volume of fluid model and species transport model together is suitable for predicting nutrient transport process. For cell proliferation, differentiation and migration, finite element method with random-walk algorithm is one the most advanced way to simulate these processes. Most of the model analysis methods require further experiments to verify the accuracy and effectiveness. Due to the lack of technology to detect the rate of nutrient diffusion, there are especially few researches on model analysis methods in the area of blood coagulation. Therefore, there is still a lot of work to be done in the research of the whole process model method of tissue engineering. In the future, the numerical model would be seen as an optimal way to investigate tissue engineering products bioperformance and also enable to optimize the parameters and material types of the tissue engineering products.

为了获得最佳的骨科植入物或再生医学产品,需要进行反复试验分析,研究合适的产品材料、结构、力学性能等。从体内试验到临床试验的整个过程既昂贵又耗时。计算模型被看作是产品开发的一种有用的分析工具。综述了一系列模拟组织工程从细胞附着到组织再生过程的模型。具有挑战性的是模拟组织工程过程的模型是单独开发的。从细胞到组织的再生,取出缺损后需进行血液注射;使细胞分散并附着在支架上;增殖、迁移和分化;直到最后一部分——成为成熟的组织。本文对组织工程过程的相关模型进行了综述,旨在为研究人员建立一个成熟的组织工程全过程模型提供契机。本文重点介绍了组织工程中细胞粘附、营养转运和细胞增殖、分化和迁移的模型分析方法。在细胞粘附模型中,最准确的方法之一是使用离散相模型来控制细胞的运动,使用Stanton-Rutland模型来模拟细胞的粘附。在养分运移模型中,数值模型与流体体积模型和物种运移模型的耦合更适合于养分运移过程的预测。对于细胞的增殖、分化和迁移,采用随机游走算法的有限元法是最先进的模拟方法之一。大多数模型分析方法需要进一步的实验来验证其准确性和有效性。由于缺乏检测营养物质扩散速率的技术,在凝血领域的模型分析方法研究尤其少。因此,组织工程全过程模型方法的研究还有很多工作要做。在未来,数值模型将被视为研究组织工程产品生物性能的最佳方法,也可以优化组织工程产品的参数和材料类型。
{"title":"Substitution for <i>In Vitro</i> and <i>In Vivo</i> Tests: Computational Models from Cell Attachment to Tissue Regeneration.","authors":"Hao Huang,&nbsp;Chao-Zong Liu,&nbsp;Teng Yi,&nbsp;Maryam Tamaddon,&nbsp;Shan-Shan Yuan,&nbsp;Zhen-Yun Shi,&nbsp;Zi-Yu Liu","doi":"10.24920/004007","DOIUrl":"https://doi.org/10.24920/004007","url":null,"abstract":"<p><p>To get an optimal product of orthopaedic implant or regenerative medicine needs to follow trial-and-error analyses to investigate suitable product's material, structure, mechanical properites etc. The whole process from <i>in vivo</i> tests to clinical trials is expensive and time-consuming. Computational model is seen as a useful analysis tool to make the product development. A series of models for simulating tissue engineering process from cell attachment to tissue regeneration are reviewed. The challenging is that models for simulating tissue engineering processes are developed separately. From cell to tissue regeneration, it would go through blood injection after moving out the defect; to cell disperse and attach on the scaffold; to proliferation, migration and differentiation; and to the final part-becoming mature tissues. This paper reviewed models that related to tissue engineering process, aiming to provide an opportunity for researchers to develop a mature model for whole tissue engineering process. This article focuses on the model analysis methods of cell adhesion, nutrient transport and cell proliferation, differentiation and migration in tissue engineering. In cell adhesion model, one of the most accurate method is to use discrete phase model to govern cell movement and use Stanton-Rutland model for simulating cell attachment. As for nutrient transport model, numerical model coupling with volume of fluid model and species transport model together is suitable for predicting nutrient transport process. For cell proliferation, differentiation and migration, finite element method with random-walk algorithm is one the most advanced way to simulate these processes. Most of the model analysis methods require further experiments to verify the accuracy and effectiveness. Due to the lack of technology to detect the rate of nutrient diffusion, there are especially few researches on model analysis methods in the area of blood coagulation. Therefore, there is still a lot of work to be done in the research of the whole process model method of tissue engineering. In the future, the numerical model would be seen as an optimal way to investigate tissue engineering products bioperformance and also enable to optimize the parameters and material types of the tissue engineering products.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"36 4","pages":"323-332"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39789407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Reliability and Validity of the Chinese Version of the Lymphedema Quality of Life Questionnaire. 中文版淋巴水肿生活质量问卷的信度和效度。
Zheng-Yun Liang, Xiao Long, E-Lan Yang, Yun-Zhu Li, Zhu-Jun Li, Min Xu, Bi-Fen Zhang, Nan-Ze Yu, Jiu-Zuo Huang

Objective To study the reliability and validity of the Chinese version of the Lymphedema Quality of Life Questionnaire (LYMQOL) in lymphedema patients. Methods LYMQOL was translated into Chinese. The Chinese version of the LYMQOL was distributed with the official Wechat account "Lymphedema Channel" to lymphedema patients who were recruited from October 28 th, 2020 to February 23rd, 2021. Patients with upper limb lymphedema and lower limb lymphedema completed the LYMQOL-ARM subscale and the LYMQOL-LEG subscale separately, at enrollment, 1 week later, and 1 month later. Reliability, validity, feasibility, responsiveness and average time required for completing the questionnaire were assessed. Results A total of 195 patients participated in the study. The Chinese questionnaire showed high reliability with Cronbach's α coefficients of 0.849-0.902 for the LYMQOL-ARM and intraclass correlation coefficient (ICC) of 0.848-0.884 and Cronbach's α coefficients of 0.726-0.902 for the LYMQOL-LEG and ICC of 0.863-0.900. The LYMQOL showed moderate to good correlations with the EQ-5D (0.4<r<0.6, P<0.01; for the LYMQOL-ARM, n=95, for the LYMQOL-LEG, n=102). Responsiveness analysis suggested that quality of life of upper limb lymphedema patients decreased after 1 month (P<0.05). The average time of patients to finish the questionnaire was approximately 12 minutes. Conclusions The Chinese version of the LYMQOL is easy to answer, comprehensive and appropriate in length, and has good reliability and validity. It may be utilized to assist treatment decision-making and track changes in clinical setting or research for lymphedema.

目的探讨中文版淋巴水肿患者生活质量问卷(lyqol)的信效度。方法将lyqol翻译成中文。中文版《淋巴水肿ol》通过微信公众号“淋巴水肿通道”发放给2020年10月28日至2021年2月23日招募的淋巴水肿患者。上肢淋巴水肿和下肢淋巴水肿患者分别在入组时、1周后和1个月后完成lyqol - arm亚量表和lyqol - leg亚量表。评估问卷的信度、效度、可行性、反应性及平均完成时间。结果共195例患者参与研究。问卷的Cronbach’s α系数为0.849 ~ 0.902,类内相关系数(ICC)为0.848 ~ 0.884;量表的Cronbach’s α系数为0.726 ~ 0.902,类内相关系数(ICC)为0.863 ~ 0.900。lyqol与EQ-5D表现出中度至良好的相关性(0.4rPn=95, lyqol - leg, n=102)。反应性分析表明,上肢淋巴水肿患者1个月后生活质量下降(P
{"title":"Reliability and Validity of the Chinese Version of the Lymphedema Quality of Life Questionnaire.","authors":"Zheng-Yun Liang,&nbsp;Xiao Long,&nbsp;E-Lan Yang,&nbsp;Yun-Zhu Li,&nbsp;Zhu-Jun Li,&nbsp;Min Xu,&nbsp;Bi-Fen Zhang,&nbsp;Nan-Ze Yu,&nbsp;Jiu-Zuo Huang","doi":"10.24920/003918","DOIUrl":"https://doi.org/10.24920/003918","url":null,"abstract":"<p><p>Objective To study the reliability and validity of the Chinese version of the Lymphedema Quality of Life Questionnaire (LYMQOL) in lymphedema patients. Methods LYMQOL was translated into Chinese. The Chinese version of the LYMQOL was distributed with the official Wechat account \"Lymphedema Channel\" to lymphedema patients who were recruited from October 28 <sup>th</sup>, 2020 to February 23<sup>rd</sup>, 2021. Patients with upper limb lymphedema and lower limb lymphedema completed the LYMQOL-ARM subscale and the LYMQOL-LEG subscale separately, at enrollment, 1 week later, and 1 month later. Reliability, validity, feasibility, responsiveness and average time required for completing the questionnaire were assessed. Results A total of 195 patients participated in the study. The Chinese questionnaire showed high reliability with Cronbach's <i>α</i> coefficients of 0.849-0.902 for the LYMQOL-ARM and intraclass correlation coefficient (<i>ICC</i>) of 0.848-0.884 and Cronbach's <i>α</i> coefficients of 0.726-0.902 for the LYMQOL-LEG and <i>ICC</i> of 0.863-0.900. The LYMQOL showed moderate to good correlations with the EQ-5D (0.4<<i>r</i><0.6, <i>P</i><0.01; for the LYMQOL-ARM, <i>n</i>=95, for the LYMQOL-LEG, <i>n</i>=102). Responsiveness analysis suggested that quality of life of upper limb lymphedema patients decreased after 1 month (<i>P</i><0.05). The average time of patients to finish the questionnaire was approximately 12 minutes. Conclusions The Chinese version of the LYMQOL is easy to answer, comprehensive and appropriate in length, and has good reliability and validity. It may be utilized to assist treatment decision-making and track changes in clinical setting or research for lymphedema.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"36 4","pages":"295-306"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39787060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Pulmonary Embolism, Thrombosis of Lower Extremity, Unexpected Mild Renal Disorder in MPO-ANCA Associated Vasculitis: A Case Report. MPO-ANCA相关血管炎的严重肺栓塞、下肢血栓形成、意外轻度肾脏疾病1例报告。
Zhong-Hua Liao, Jun-Tao Feng, Jia-le Tang, Li-Ying Luo, Xiao-Zhao Li

Myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) associated vasculitis is an autoimmune disease usually with severe multiple dysfunction syndrome, especially prominent acute renal failure. A 65-year-old woman was admitted with progressive dyspnoea for six months and fever, sputum with blood, pain of the lower extremities and intermittent claudication for two days, indicating multiple organ involvement (respiratory system, blood vessels). The renal involvement was relatively mild, presenting with microscopic haematuria. The chest computed tomography demonstrated multiple pulmonary embolisms. Ultrasound and computed tomography angiography for the lower extremity vessels showed venous and arterial thrombosis. Exclusion of other diseases that can cause multiple organ damage and thrombosis, the positive perinuclear ANCA and MPO-ANCA strongly support the diagnosis of MPO-ANAC-associated vasculitis. The patient's physical condition has been greatly improved by treatment with corticosteroids and anticoagulation.

髓过氧化物酶抗中性粒细胞胞浆抗体(MPO-ANCA)相关性血管炎是一种自身免疫性疾病,通常伴有严重的多种功能障碍综合征,尤其是急性肾功能衰竭。一名65岁妇女因进行性呼吸困难住院6个月,并伴有发热、带血痰、下肢疼痛和间歇性跛行2天,表明累及多器官(呼吸系统、血管)。肾脏受累相对轻微,显微镜下表现为血尿。胸部计算机断层扫描显示多发肺栓塞。下肢血管超声及计算机断层血管造影显示静脉及动脉血栓形成。排除其他可引起多器官损害和血栓形成的疾病,核周ANCA和MPO-ANCA阳性有力地支持mpo - anac相关血管炎的诊断。经皮质类固醇和抗凝治疗,病人的身体状况有了很大改善。
{"title":"Severe Pulmonary Embolism, Thrombosis of Lower Extremity, Unexpected Mild Renal Disorder in MPO-ANCA Associated Vasculitis: A Case Report.","authors":"Zhong-Hua Liao,&nbsp;Jun-Tao Feng,&nbsp;Jia-le Tang,&nbsp;Li-Ying Luo,&nbsp;Xiao-Zhao Li","doi":"10.24920/003871","DOIUrl":"https://doi.org/10.24920/003871","url":null,"abstract":"<p><p>Myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) associated vasculitis is an autoimmune disease usually with severe multiple dysfunction syndrome, especially prominent acute renal failure. A 65-year-old woman was admitted with progressive dyspnoea for six months and fever, sputum with blood, pain of the lower extremities and intermittent claudication for two days, indicating multiple organ involvement (respiratory system, blood vessels). The renal involvement was relatively mild, presenting with microscopic haematuria. The chest computed tomography demonstrated multiple pulmonary embolisms. Ultrasound and computed tomography angiography for the lower extremity vessels showed venous and arterial thrombosis. Exclusion of other diseases that can cause multiple organ damage and thrombosis, the positive perinuclear ANCA and MPO-ANCA strongly support the diagnosis of MPO-ANAC-associated vasculitis. The patient's physical condition has been greatly improved by treatment with corticosteroids and anticoagulation.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"36 4","pages":"342-345"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39789409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1